Outpatient administration of epcoritamab monotherapy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Results from EPCORE NHL-6 by race and ethnicity
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Adelba Torres, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Haydu, Bradley Lash, Mark Fesler, John Hrom, Eric Lee, Suchitra Sundaram, Kristin Conte, Kojo Osei-Bonsu, Yang Bai, Christian Eskelund, Alexander Boardman, Ralph Vincent Boccia, Christina Lee, David Andorsky, Jeff Sharman
Institutions: Auxilio Mutuo Hospital, Atrium Health Wake Forest Baptist, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Penn State Cancer Institute, Virginia Cancer Specialists, Massachusetts General Hospital, Hattiesburg Clinic, Forrest General Hospital, Compassionate Cancer Care, Icahn School of Medicine at Mount Sinai, AbbVie (United States), Genmab (Denmark), Memorial Sloan Kettering Cancer Center, Center for Cancers and Blood Disorders, Stony Brook University, Rocky Mountain Cancer Centers, Willamette Valley Cancer Institute and Research Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019675
Cites:
Cited by:
Related to: